Wilmington, DE, United States of America

Alvin K Willard

This inventor holds 10 USPTO granted patents. Top assignees: Merck + Co., Inc., Ici Americas, Inc.. Active years: 1981-1987.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alvin K Willard. Retrieved from https://idiyas.com/inventor/alvin-k-willard

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 2.7

ph-index = 9

Forward Citations = 613(Granted Patents)


Location History:

  • Lansdale, PA (US) (1981)
  • DE, US (1984)
  • Wilmington, DE (US) (1983 - 1987)

Company Filing History:


Years Active: 1981-1987

Loading Chart...
10 patents (USPTO):Explore Patents

Title: **The Innovative Journey of Alvin K. Willard**

Introduction

Alvin K. Willard, based in Wilmington, Delaware, is an accomplished inventor known for his significant contributions to the field of pharmaceutical chemistry. With a total of ten patents, his work primarily focuses on inhibitors of cholesterol synthesis, demonstrating a strong commitment to advancing medical science.

Latest Patents

Willard’s latest innovations include two noteworthy patents related to substituted pyranone inhibitors of cholesterol synthesis. The first patent details the 6-Phenyl-, phenylalkyl-, and phenylethenyl-4-hydroxytetrahydropyran-2-ones, which are recognized as potent inhibitors of cholesterol synthesis. This is achieved through their capacity to inhibit the enzyme 3-hydroxy-3-methylglutaryl-coenzyme A reductase. The second patent describes the methyl, ethyl, n-propy, and several other esters of E-(3R,5S)-7-(4'-fluoro-3,3',5-trimethyl[1,1'-biphenyl]-2-yl)-3,5-dihydroxy-6-heptenoic acid, which serve as HMG-CoA reductase inhibitors beneficial for treating conditions associated with hypercholesterolemia.

Career Highlights

Throughout his career, Willard has held positions at notable companies such as Merck & Company, Inc. and ICI Americas, Inc. His experiences in these prominent organizations have significantly influenced his research and development work, allowing him to refine his innovative ideas and drive forward critical advancements in pharmaceutical sciences.

Collaborations

Collaboration has been a key element of Willard's career, with notable coworkers including William F. Hoffman and Robert L. Smith. Together, they have worked on groundbreaking projects that focus on enhancing the understanding and treatment of cholesterol-related health issues, exemplifying teamwork in the scientific community.

Conclusion

Alvin K. Willard stands out as a pivotal figure in the realm of pharmaceutical patents, particularly concerning cholesterol synthesis inhibitors. His dedication, innovative spirit, and collaborative efforts underscore his impactful contributions to medical science, paving the way for future advancements in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…